Understand how companies partner across the animal health industry using intelligence from 294 real-world agreements.
Animal Health Partnering Terms and Agreements 2017-2026 provides comprehensive intelligence on 294 partnering deals involving animal health products, technologies and development programs.
Partnerships play an important role throughout the animal health industry, enabling companies to access innovation, combine research and development capabilities, secure rights to products and technologies, expand manufacturing capacity and extend commercial reach.
These relationships can take many forms, from early research and development collaborations through to licensing, manufacturing, supply, distribution and commercialization agreements.
The report brings this activity together in one resource, enabling users to understand who is partnering, which deal structures are being used, where activity is concentrated, what financial terms have been disclosed and how companies are working together across development and commercialization.
Rather than focusing on a single transaction type, the report provides a broad view of animal health partnering across veterinary medicines, vaccines, diagnostics and related animal health technologies.
It combines market-wide deal analysis with financial benchmarking, leading dealmaker intelligence, detailed transaction records and access to publicly available contract documents where available.
The report is designed for business development, licensing, corporate strategy, R&D, commercial strategy, competitive intelligence and legal teams involved in animal health partnering.
This provides real-world reference points for internal benchmarking, opportunity assessment, deal preparation and negotiation.
Financial benchmarks are most useful when interpreted alongside the structure, development stage, rights and circumstances of comparable transactions rather than as standalone averages, and the report provides the underlying deal intelligence needed to establish that context.
Identify comparable animal health transactions, prospective partners and relevant agreement structures.
Animal Health Companies
Benchmark partnering activity, investigate potential partners and understand how peer companies are accessing external products and technologies.
Pharmaceutical and Biotechnology Companies
Understand partnering activity in animal health and identify organizations actively developing and commercializing veterinary products and technologies.
Companies Seeking Animal Health Partners
Identify organizations with demonstrated interest in relevant products, technologies, disease areas and stages of development.
Corporate and R&D Strategy teams
Track how companies are using external partnerships to access innovation and build animal health portfolios.
Commercial and Market Strategy teams
Investigate distribution, commercialization and other partnerships used to extend the reach of animal health products.
Competitive and Market Intelligence teams
Analyze activity by company, technology, disease area, stage and transaction type to understand evolving strategic priorities.
Legal and Transaction teams
Review publicly available agreements and precedent structures to support transaction preparation and negotiation.
The briefing applies the underlying animal health deal intelligence to the customer's own products, technologies, portfolio or partnering objectives.
Depending on requirements, this can include relevant comparable transactions, prospective partners, competitor activity, deal structures, development-stage analysis, financial benchmarks, royalty analysis, contract insights and other intelligence selected specifically for the client's situation.
Animal Health Partnering Terms and Agreements 2017-2026 provides comprehensive intelligence on 294 partnering deals involving animal health products, technologies and development programs.
Partnerships play an important role throughout the animal health industry, enabling companies to access innovation, combine research and development capabilities, secure rights to products and technologies, expand manufacturing capacity and extend commercial reach.
These relationships can take many forms, from early research and development collaborations through to licensing, manufacturing, supply, distribution and commercialization agreements.
The report brings this activity together in one resource, enabling users to understand who is partnering, which deal structures are being used, where activity is concentrated, what financial terms have been disclosed and how companies are working together across development and commercialization.
Rather than focusing on a single transaction type, the report provides a broad view of animal health partnering across veterinary medicines, vaccines, diagnostics and related animal health technologies.
It combines market-wide deal analysis with financial benchmarking, leading dealmaker intelligence, detailed transaction records and access to publicly available contract documents where available.
The report is designed for business development, licensing, corporate strategy, R&D, commercial strategy, competitive intelligence and legal teams involved in animal health partnering.
Understand the animal health partnering landscape
The report analyzes animal health dealmaking from 2017 to 2026, including:
- Trends in partnering activity by year
- Most active animal health dealmakers
- Partnering activity by deal type
- Therapy and disease area
- Technology type
- Stage of development
- Leading deals by disclosed value
- Financial terms where available
- How animal health partnering strategies are evolving
Compare different animal health partnership models
Animal health partnerships can be structured in many different ways according to the product, technology, development stage, market opportunity and capabilities of the parties.The report enables users to investigate multiple approaches, including:
- Research and development collaborations
- Licensing agreements
- Development partnerships
- Manufacturing and supply arrangements
- Distribution agreements
- Commercialization partnerships
- Other multi-component transactions
Benchmark animal health deal financials
The report provides dedicated analysis of disclosed financial terms across animal health partnering transactions, including:
- Headline deal values
- Upfront payments
- Milestone payments
- Royalty rates
This provides real-world reference points for internal benchmarking, opportunity assessment, deal preparation and negotiation.
Financial benchmarks are most useful when interpreted alongside the structure, development stage, rights and circumstances of comparable transactions rather than as standalone averages, and the report provides the underlying deal intelligence needed to establish that context.
Identify leading animal health dealmakers and prospective partners
The report identifies the most active animal health dealmakers and provides company-level transaction histories that enable users to investigate their previous partnering activity.This can help users identify:
- Companies actively seeking external opportunities
- Prospective licensing and collaboration partners
- Organizations repeatedly active in particular animal health areas
- Companies with demonstrated interest in specific technologies
- Dealmakers active at relevant stages of development
- Potential commercial, distribution or development partners
- Competitors pursuing similar external innovation strategies
Understand where animal health partnering activity is concentrated
The report analyzes animal health transactions by:
- Deal type
- Therapy or disease area
- Technology type
- Stage of development
- Company
Understand how animal health agreements are structured
Depending on the transaction and available disclosure, users can investigate areas including:
- Rights granted and retained
- Research and development responsibilities
- Licensing scope
- Exclusivity
- Geographic and territorial rights
- Intellectual property
- Development and regulatory obligations
- Manufacturing and supply
- Distribution and commercialization responsibilities
- Financial consideration
- Milestones and royalties
- Governance
- Term and termination provisions
Learn from real-world contract documents
Where publicly available, the report provides access to underlying contract documents for selected animal health transactions.These agreements can provide substantially more detail than company announcements alone, enabling users to examine how partners have documented matters including:
- Scope of rights
- Intellectual property
- Development obligations
- Exclusivity and territory
- Financial terms
- Milestone triggers
- Royalty provisions
- Manufacturing and supply
- Commercialization responsibilities
- Termination and continuing rights
Comprehensive animal health deal directory
The report includes a comprehensive directory of 294 animal health partnering deals, providing a focused resource for identifying relevant precedent transactions and companies.Deals can be investigated by:
- Company
- Stage of development
- Deal type
- Therapy or disease area
- Technology type
- Contract availability
Who should use this report?
Business Development and Licensing teamsIdentify comparable animal health transactions, prospective partners and relevant agreement structures.
Animal Health Companies
Benchmark partnering activity, investigate potential partners and understand how peer companies are accessing external products and technologies.
Pharmaceutical and Biotechnology Companies
Understand partnering activity in animal health and identify organizations actively developing and commercializing veterinary products and technologies.
Companies Seeking Animal Health Partners
Identify organizations with demonstrated interest in relevant products, technologies, disease areas and stages of development.
Corporate and R&D Strategy teams
Track how companies are using external partnerships to access innovation and build animal health portfolios.
Commercial and Market Strategy teams
Investigate distribution, commercialization and other partnerships used to extend the reach of animal health products.
Competitive and Market Intelligence teams
Analyze activity by company, technology, disease area, stage and transaction type to understand evolving strategic priorities.
Legal and Transaction teams
Review publicly available agreements and precedent structures to support transaction preparation and negotiation.
Turn market-wide animal health intelligence into company-specific insight
For qualifying customers, the analyst can also provide a Customized Executive Partnering Briefing alongside the report.The briefing applies the underlying animal health deal intelligence to the customer's own products, technologies, portfolio or partnering objectives.
Depending on requirements, this can include relevant comparable transactions, prospective partners, competitor activity, deal structures, development-stage analysis, financial benchmarks, royalty analysis, contract insights and other intelligence selected specifically for the client's situation.
Table of Contents
Executive SummaryChapter 1 - Introduction
Chapter 2 - Trends in animal health dealmaking
Chapter 3 - Leading animal health deals
Chapter 4 - Most active animal health dealmakers
Chapter 5 - Animal health contracts dealmaking directory
Chapter 6 - Animal health dealmaking by technology type
Table of figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbCellera Biologics
- Ab E Discovery
- Absorption Systems
- AcuraBio
- AdaptVac
- Adisseo
- ADM
- Advanced Animal Diagnostics
- Aeronics
- AgBiome
- AGC Biologics
- Agricultural Research Organization
- Aimia Pet Health
- AKL Research and Development
- Akston Biosciences
- Algenex
- ALK-Abello
- Allegro
- ALR Technologies
- Altro Pharmaceuticals
- Alveolus
- Alveo Technologies
- AmacaThera
- American Regent
- American Veterinary Medical Foundation
- Anatara Lifesciences
- Angany
- Animal Allergy Clinical Laboratories
- AnimalBiome
- Animalcare
- Animal Clinical Investigation
- Animal Life Sciences
- Anivive Lifesciences
- Ankyra Therapeutics
- Apacor
- Applied BioSciences
- Applied DNA Sciences
- Aptimmune Biologics
- Aratana Therapeutics
- Arcturus Therapeutics
- Argenta
- Aridis Pharmaceuticals
- Arysta LifeScience
- AskAt
- Assisi Animal Health
- Atomwise
- Aurelius Biotherapeutics
- Aurinia Pharmaceuticals
- Australian Research Council
- Avacta
- Avivagen
- Basepaws
- BASF
- Bayer
- Bayer Animal Health
- Better Choice Company
- Better Choice Products
- Big Barker
- BioChek
- BioCopy
- BioInvent
- BioIVT
- BiomEdit
- BioTecon Diagnostics
- Blacksmith Medicines
- Blackstone
- Blue Buffalo Company
- BodeVet
- Boehringer Ingelheim
- Boehringer Ingelheim Vetmedica
- Bond Pet Foods
- Boragen
- Brainomix
- Broad Institute
- Buhler
- Calysta Energy
- CannaSoul Analytics
- CannPal Animal Therapeutics
- CAPInnoVet
- Cardiff University
- cbdMD
- Celsee
- Central Institute for Experimental Animals
- Centrovet
- Ceva Sante Animale
- Charles River Laboratories
- Choom
- Colorado State University
- Conduit Pharmaceuticals
- Cornell University
- Cornerstone Animal Health
- COTA
- Covenant Animal Health Partners
- Covetrus
- Cresilon
- CSA Medical
- CSIRO
- CURE Pharmaceutical
- Curio Genomics
- CVM Ecografía
- Daiichi Sankyo
- Danish Innovation Fund
- Dawn Health
- Dechra Pharmaceuticals
- Deinove
- Delf
- Department of Defense
- Destination Pet
- Diversigen
- Domes Pharma
- Dovetail Genomics
- Dragonfly Therapeutics
- DSM
- DW Healthcare
- Dyadic International
- EBOS Group
- Eko Health
- Elanco
- ELIAS Animal Health
- Emergent BioSolutions
- Emollivet
- Energesis Pharmaceuticals
- Enveric Biosciences
- Envigo
- EPiQ Animal Health
- epitoMAP
- Epivax
- eQcell
- EQT
- Esteve
- Ethos Discovery
- Ethos Veterinary Health
- Eurocine Vaccines
- Evah
- Evax
- Evonik Industries
- Evotec
- Evvivax
- Express Scripts
- Eyebiotech
- Eyegate Pharmaceuticals
- ezyVet
- Fatro
- FDA Center for Veterinary Medicine
- Felix Biotechnology
- Flagship Pioneering
- Food and Drug Administration (FDA)
- Formation Bio
- Forte Biotechnology
- Fraunhofer Institute for Cell Therapy and Immunology
- Front Range Laboratories
- FSD Pharma
- Gallant Therapeutics
- Galmed Pharmaceuticals
- GE Healthcare
- Gencove
- Genelux
- Genetic Veterinary Sciences
- Ginkgo BioWorks
- Global Access Diagnostics
- Global Dx
- Global Stem Cell Technology
- Globion
- Glycovax Pharma
- GNA Biosolutions
- Gnubiotics Sciences
- Government of Australia
- Greenlight Biosciences
- Grovet
- GrowSafe Systems
- Grunenthal
- Gryphon Investors
- HappyBond
- Harvard T.H. Chan School of Public Health
- Heiland
- HemPup
- Hendrix Genetics
- Henry Schein
- Heska
- Hill's Pet Nutrition
- Horizon Discovery
- Huvepharma
- IdentiGEN
- IDEXX Laboratories
- Ilender
- Illumina
- Immune Therapeutics
- Immunomic Therapeutics
- Impact NRS
- Imugene
- IncellDx
- India Globalization Capital
- Infinovo Medical
- Innovate UK
- Innovet
- Inovalon
- Inovet
- Inphilco
- Insilico Medicine
- Institute of Virology and Immunology
- IntelGenx
- Interpath Global
- Intrexon
- Invetx
- Jaguar Health
- Jenga Biosciences
- JP Equine Services
- Jurox
- Kahu Vet Group
- Kane Biotech
- Kansas State University
- Karyopharm Therapeutics
- Kemin Industries
- KeraVet Bio
- Kermode Biotechnologies
- Kincell Bio
- Kindred Bio
- Kiora Pharmaceuticals
- Konica Minolta
- KulKote
- KVP International
- Laboratorios Adler
- Lacuna Diagnostics
- Leiber
- LexaGene
- LIC Automation
- LightDeck Therapeutics
- Lighthouse Pharmaceuticals
- Liiv Organics
- Likarda
- LineaRx
- Lipidor
- LiteCure Medical
- Livestock Improvement
- Loop Genomics
- LSPediA
- Lumosa Therapeutics
- Lygos
- Lytix Biopharma
- Magdalena Biosciences
- Magiar Chilena
- Makana Therapeutics
- Manoira Corporation
- Marrone Bio Innovations
- Mars Petcare
- MBF Therapeutics
- MBP Solutions
- Med-Pharmex
- MedGene Bioscience
- MediCann Handels
- MedinCell
- MediSapiens
- Merck and Co
- Merck Animal Health
- Midori USA
- Miller Veterinary Supply East
- Mimi’s Rock
- Mitsubishi Tanabe Pharma
- Moderna
- Moleculin Biotech
- Mologic
- Morris Animal Foundation
- Mountain Valley MD
- MSD Animal Health
- MWI Animal Health
- MyoKardia
- MYOS
- Nanomix
- NanoSmart Pharmaceuticals
- National Institute for Biotechnology in the Negev
- National Veterinary Associates
- Nature-Cide
- Neogen
- Neptune Technologies & Bioressources
- Nerio Therapeutics
- Neurizon Therapeutics
- NeuroCycle Therapeutics
- NewLeaf Brands
- New Ruipeng Group
- Nextmune
- Nexvet
- Nirvana Group
- Nona Biosciences
- Nong San Viet
- Nortev
- Novovet
- Novozymes
- Nrgene
- Nufarm
- Nuritas
- NutraMax
- NutriQuest
- NWO.ai
- NXTGEN
- NYtor
- Ocular Therapeutix
- Okava Pharmaceuticals
- Ology Bioservices
- Oncology Pharma
- Ontera
- OpenAI
- Orion
- Pacific Biosciences
- Pacific GeneTech
- PARI
- Pathogens and Environmental Solutions
- Patient Square Capital
- Patterson Companies
- PBI-Gordon Companies
- Pebble Labs
- Penn Veterinary Supply
- Performance Livestock Analytics
- Perrigo
- Pestmaster Services
- PetCareRx
- Petco
- PetDx
- PetIQ
- PetLife Pharmaceuticals
- PetMed Express
- Petriage
- PetVivo
- Pfizer
- PharmaCielo
- PHAXIAM Therapeutics
- Phibro Animal Health
- Phyto Animal Health
- Plandai Biotechnology
- PlantForm
- Pond Technologies
- POSCO International
- Poultry Sense
- Poxel
- Precigen
- Prelude Therapeutics
- Primordial Genetics
- ProBioGen
- ProFound Therapeutics
- ProtonDx
- Provet
- PulseVet
- Purdue Research Foundation
- Purdue University
- PureKana
- Purina
- Qorvo Biotechnologies
- Quantified Ag
- Queensland University of Technology
- Redbarn Pet Products
- Regen BioPharma
- Regeneron Pharmaceuticals
- RegenLab
- Rejuvenate Bio
- Reliance Animal Health Partners
- Restoration Biologics
- Revive & Restore
- Revo Squared
- Riemser
- Ripe Technology
- Royal GD
- Saiba Animal Health
- Sanofi
- Sasaeah Pharmaceutical
- Science Biotech
- Scil Animal Care
- Scynexis
- Seed Mena
- Senestech
- Sentrx Animal Care
- Sharp Edge Labs
- Simulations Plus
- SIRE Veterinario
- Skout’s Honor Pet Supply Company
- Skyline Vet Pharma
- Sleip
- Sonoma Pharmaceuticals
- Sound Technologies
- Southwest Research Institute
- SRx Health
- STEM Animal Health
- Stonehaven Incubate
- Structured Monitoring Products
- Sumitomo Dainippon Pharma
- Syngene
- Syngenta
- Synthetic Genomics
- Syntr Health Technologies
- SynWorld Technologies
- Takis Biotech
- Target Specialty Products
- Techcyte
- Technology Acceleration Partners
- TeleVet
- Telomir Pharmaceuticals
- Tetra Bio-Pharma
- Tetracore
- Tiba Biotech
- Tissue Dynamics
- Titan Pharmaceuticals
- TONIX Pharmaceuticals
- Torigen Pharmaceuticals
- Toronto Innovation Acceleration Partners
- Trans Ova Genetics
- Trianni
- TriRx Pharmaceutical Services
- TriviumVet
- Tufts University
- Twist Bioscience
- UNION Therapeutics
- Universite Laval
- University of California
- Davis
- University of Connecticut
- University of Glasgow
- University of Illinois Urbana-Champaign
- University of Liverpool
- University of Prince Edward Island
- University of Queensland
- University of Surrey
- University of Vermont
- University of Zurich
- US Department of Agriculture
- Valent Biosciences
- Vaxinano
- VCA Antech
- VCP
- Vence
- Verios Agro
- VERT
- Vet-Allergy
- Vetcor
- Veterinary Pharmacology Research Foundation
- Vetigenics
- Vetnique Labs
- VetNOW
- Vetophage
- Vetoquinol
- Vets First Choice
- VetStem
- Victor Medical
- Victor Medical Company
- Vida Concepts
- Vigil Neuroscience
- Vimian Group
- Virbac
- Vita Bee Health
- VitalPet
- VitalRADS
- Vitanova Biomedical
- Vium
- Vivaldis
- Vivani Medical
- VolitionRX
- Vuja De Sciences
- Vytelle
- Wanda Fish Technologies
- Wedgewood Pharmacy
- Wildlife Pharmaceuticals
- Woodley Equipment Company
- World Pet Care Products Company
- Zander Therapeutics
- Zenfold Sustainable Technologies
- Zenoaq
- Zenyaku Kogyo
- Zesty Paws
- Zivo Bioscience
- Zoetis
- Zomedica
- Zydus Cadila
- Zymeworks
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...
